Prosecution Insights
Last updated: November 04, 2026
Application No. 18/636,014

SYNTHESIS OF POLY(PHENYLENE) COMPOUND INTERGRATED WITH FUNCTIONALIZED FLUORENE PORTION FOR ION EXCHANGE IONOMER AND ION EXCHANGE IONOMER

Non-Final OA §112
Filed
Apr 15, 2024
Priority
Nov 02, 2021 — provisional 63/274,621 +4 more
Examiner
TESKIN, FRED M
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
USA Fortescue IP, INC.
OA Round
1 (Non-Final)
90%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 90% — above average
90%
Career Allowance Rate
1211 granted / 1351 resolved
+24.6% vs TC avg
Moderate +8% lift
Without
With
+7.9%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
26 currently pending
Career history
1382
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
34.6%
-5.4% vs TC avg
§102
22.4%
-17.6% vs TC avg
§112
30.8%
-9.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1351 resolved cases

Office Action

§112
DETAILED ACTION Status of Application This action is responsive to continuing application filed 04/15/2024 as a C-I-P of international application No. PCT/US22/48352, filed on 10/31/2022. Original claims 1-20 are currently pending and under examination herein. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Objection – Specification The disclosure is objected to because of the following informalities: Referring to paragraphs [0005]-[0007], [0012]-[0013] and [0025], an error in nomenclature is noted: “n-methyl piperidine” (all occurrences) should read –N-methyl piperidine-- (cf., ¶ [0076]). The specification is objected to as failing to provide proper antecedent basis for the claimed subject matter. See 37 CFR 1.75(d)(1) and MPEP § 608.01(o). Correction of the following is required: failure to provide proper antecedent basis for the claimed subject matters of: “Cerium (Ce), Manganese (Mn), phenolic compounds, nitrogen-containing heterocyclic compounds, quinones, amine, phosphites, phosphonites, and thioesters” (see claim 13); “hygroscopic inorganic filler” (see claim 14); “oxides of aluminum, silicon, titanium, zirconium and zirconium phosphate, cesium phosphate, zeolites, clays and carbon black, multiwall carbon nanotubes, reduced graphene oxide” (see claims 15, 20); and “crosslinking agent that includes a tertiary diamine head groups which include DABCO (1,4-diazabicyclo[2,2,2]octane) and TMHDA (N,N,N,N-tetramethylhexane diammonium), 1,4-diiodobutane” (see claim 16). Appropriate correction of the specification is required. Objection – Claims Claims 2-6 are objected to because of the following informalities: all occurrences of “phenelyne” should be corrected to read –phenylene-- (cf., claim 1, line 2). Claim 11 is objected to because of the following informalities: “n-methyl piperidine” should be corrected to –N-methyl piperidine-- (cf., Spec., ¶ [0076]). Claims 15 and 20 are objected to because of the following informalities: omission of the conjunction –and-- between the final two members of the recited Markush group (cf., claim 13). Claim 16 is objected to because of the following informalities: referring to line 3, it is presumed that “and” was intended to read –or--, as it appears unlikely that the crosslinking agent is both of “DABCO (1,4-diazabicyclo[2,2,2]octane)” and “TMHDA (N,N,N,N-tetramethylhexane diammonium)” together. Appropriate correction of the above-noted claims is required. Claim Rejections – 35 U.S.C. 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 2 and 15-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claim 2, the recitation “ratio of the (fluorene) compound concentration to the (phenelyne) structure concentration is 1:1” creates indefiniteness as it is unclear what concentration the ratio is expressing. That is, does the numerical ratio reflect a molar ratio, a weight ratio, or a volume ratio of concentrations of the recited (fluorene) compound and (phenylene) structure? It is unclear how the ratio is to be determined for purposes of assessing the applicability of prior art. Clarification and appropriate correction are required. Regarding Claim 15, the claim recites “wherein the filler is a carbon-based materials selected from …” but the subsequently listed Markush members include multiple filler species that are not carbon based materials. It is unclear how “carbon-based” is intended to serve as a limitation for the various named species other than “carbon black, multiwall carbon nanotubes, reduced graphene oxide.” Clarification and appropriate correction are required. Regarding Claim 16, the claim is internally inconsistent in first reciting “crosslinking agent includes a tertiary amine head groups …” and then listing “1,4-diodobutane,” as a species of crosslinking agent. The latter compound obviously lacks the recited head group(s) functionality and is not mentioned in the antecedent disclosure at all. Clarification and appropriate correction are required. Pertinent Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Page et al (US 2020/0313215 A1) is cited merely to show analogous art; i.e., art relating to membranes (e.g., an anion conducting membrane) that may include a crosslinked ionomer exemplified by the structure: PNG media_image1.png 494 713 media_image1.png Greyscale (See, ¶ [0039] and Fig. 3C). The citation does not teach the present invention, especially a co-polymer having a structure as defined in present claim 1. Allowable Subject Matter Claims 1, 7-10, 12-14, and 17-19 are allowed. Balance of the claims would be allowable if amended or rewritten to overcome the objections (re: claims 2-6, 11, 15-16, 20) and rejections under 35 U.S.C. 112 set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: pending claims are deemed to distinguish over the closest prior art as represented by Xu, et al (ACS Macro Lett. 2021, 10, 1180-1185) and Bahar, et al (US 2020/0406248 A1). Applicant claims an ion-conducting co-polymer comprising: a) a polymeric backbone comprising repeat units of a (phenylene) compound covalently bonded directly to a (fluorene) compound to produce co-poly(phenylene)-(fluorene); wherein the (phenylene) compound comprises benzene rings; wherein the benzene rings produce steric hinderance of the ion conducting co-polymer; wherein said (fluorene) compound has a 9H-fluorene structure that is a polycyclic aromatic hydrocarbon having a center ring with five carbon atoms, and a benzene ring on each of opposing sides of said center ring; and a pair of sidechains extending from the center ring to a respective terminal group; and wherein said (phenylene) compound is covalently bonded to each of said benzene rings of the (fluorene) compound; b) two side chains extending from the (fluorene) compound; and c) functional groups. (Claim 1) Xu, et al disclose ether-free polyfluorene-based anion exchange membranes for fuel cell applications (Abs., pp. 1181-82, bridging paragraph). In particular, Xu, et al describe synthesis of poly[(9,9-bis(6’-bromohexyl)fluorene)-co-bis(phenyl)-ethane] (PFPE-Br) which has the structure: PNG media_image2.png 211 284 media_image2.png Greyscale (p. 1181, Scheme 1). The structure of the polymer described in Xu, et al does not have benzene rings covalently bonded to the poly(phenylene) as side chains and is made up of poly(fluorene) and poly(bibenzyl) instead of poly(phenylene) as in the present invention (cf., claim 1, lines 2-4 and 8-13). Bahar, et al is directed to ultra-thin anion exchange membranes incorporating anion exchange polymers and functional additives (¶ [0002]). Exemplary anion exchange polymers as shown in Figs. 1A and 1B thereof clearly lack the structure defined in subparagraph a) of present claim 1; and Bahar, et al. is not otherwise seen to describe or suggest the co-polymer structure requisite to the instant invention. Furthermore, a search of the relevant art has revealed no prior art that can be used, either singularly or in combination with another reference including Xu, et al. or Bahar, et al., to render the presently claimed invention anticipated or obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention. Correspondence Any inquiry concerning this communication should be directed to Examiner F. M. Teskin whose telephone number is (571) 272-1116. The examiner can normally be reached on Monday through Friday from 9:00 AM - 5:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Robert Jones, can be reached at (571) 270-7733. The appropriate fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center for authorized users only. Should you have questions about access to Patent Center, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/patents/uspto-automated- interview-request-air-form. /FRED M TESKIN/Primary Examiner, Art Unit 1762 /FMTeskin/09-10-26
Read full office action

Prosecution Timeline

Apr 15, 2024
Application Filed
Sep 15, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780965
PELLET-TYPE POLYETHYLENE RESIN COMPOSITION AND METHOD FOR PREPARING THE SAME
4y 4m to grant Granted Nov 03, 2026
Patent 12781363
MEMBRANE ELECTRODE ASSEMBLY FOR WATER ELECTROLYSIS, WATER ELECTROLYSIS CELL INCLUDING THE MEMBRANE ELECTRODE ASSEMBLY AND METHOD FOR FABRICATING THE MEMBRANE ELECTRODE ASSEMBLY
4y 1m to grant Granted Nov 03, 2026
Patent 12780990
RESIN COMPOSITION FOR ENCAPSULATING SEMICONDUCTOR ELEMENT-MOUNTED SURFACE OF SUBSTRATE WITH SEMICONDUCTOR ELEMENT MOUNTED THEREON OR SEMICONDUCTOR ELEMENT-FORMING SURFACE OF WAFER WITH SEMICONDUCTOR ELEMENT FORMED THEREON, AND USE THEREOF
3y 5m to grant Granted Nov 03, 2026
Patent 12780968
METHOD FOR PRODUCING FLUOROPOLYMER
3y 4m to grant Granted Nov 03, 2026
Patent 12781064
Polythiophene/Polyanion Compositions
2y 11m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
90%
Grant Probability
98%
With Interview (+7.9%)
2y 1m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1351 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month